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Optimal Number of Endoscopic Biopsies in Diagnosis of 
Advanced Gastric and Colorectal Cancer
Endoscopic biopsy is necessary to confirm a histopathologic diagnosis. Currently, 6 to 8 
biopsies are recommended for diagnosis of a suspected malignant lesion. However, 
multiple biopsies may result in several problems, such as an increased risk of bleeding, 
procedure prolongation, and increased workload to pathologists. The aim of this study was 
to clarify the optimal number of endoscopic biopsy specimens required in diagnosis of 
advanced gastrointestinal cancer. Patients who were diagnosed with advanced 
gastrointestinal cancer during endoscopy were included. Five specimens were obtained 
sequentially from viable tissue of the cancer margin. Experienced pathologists evaluated 
each specimen and provided diagnoses. A total of 91 patients were enrolled. Fifty-nine 
subjects had advanced gastric cancer, and 32 had advanced colon cancer. Positive 
diagnosis rates of the first, second, and third advanced gastric cancer specimens were 
81.3%, 94.9%, and 98.3%, respectively, while positive diagnosis rates of advanced colon 
cancer specimens were 78.1%, 87.5%, and 93.8%. Further biopsies did not increase 
positive diagnosis cumulative rates. This study demonstrated that three specimens were 
sufficient to make correct pathologic diagnoses in advanced gastrointestinal cancer. 
Therefore, we recommend 3 or 4 biopsies from viable tissue in advanced gastrointestinal 
cancer to make a pathologic diagnosis during endoscopy.
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INTRODUCTION
Since fiberscope was introduced in 1958, gastroscopy and colo-
noscopy have made large contributions in the diagnosis of gas-
trointestinal disease; additionally, the development of the video 
endoscope provided further diagnostic improvement (1, 2). Dur-
ing endoscopy, multiple biopsies are often necessary to diag-
nose cancer at the potential malignant lesion site in the stom-
ach or colon as a standard diagnostic tool for pathologic confir-
mation. Twenty to thirty years ago, the number of endoscopic 
biopsy specimens needed to diagnose gastric or colon cancer 
during fiberoptic endoscopy varied from 4 to 10 (3-6). However, 
the increase in the number of biopsies performed may cause 
an increased risk of complications, such as gastrointestinal bleed-
ing. Only a few recent reports have been published on the opti-
mal number of endoscopic biopsy specimens required to cor-
rectly diagnose gastric or colon cancer. Currently, we can rou-
tinely differentiate malignant from benign lesions according to 
the endoscopic finding. Furthermore, with the development of 
the video-endoscope instrument, we could get a wider vision, 
and better targeting to the suspicious lesion, that leads to a re-
duced number of biopsy specimens needed to diagnose malig-
nancy. The aim of this study was to clarify the optimal number 
of endoscopic biopsy specimens in lesions suspected as ad-
vanced gastric and colon cancer.
MATERIALS AND METHODS
A total of 91 patients who underwent diagnostic gastroscopy and 
colonoscopy for various gastrointestinal symptoms at the Kang-
buk Samsung Hospital from January 2006 to May 2007 was in-
cluded in this study. All patients enrolled in this study were di-
agnosed with advanced gastric or colon cancer by endoscopy 
which was subsequently confirmed by surgical pathologic diag-
nosis. Upper endoscopic examinations were performed using 
forward viewing standard electronic video gastroscopes (EC-
450WR5; Fujinon Co. Ltd., Saitama, Japan) between 8:00 a.m. and 
12:00 a.m. after an overnight fast. Colonoscopy was performed 
using standard electronic video colonoscopes (EC-450WM5; 
Fujinon Co. Ltd.) between 2:00 p.m. and 5:00 p.m. after an over-
night fast. Bowel preparation was accomplished by instructing 
patients to drink 4 L of a polyethylene glycol-electrolyte solution 
(Colonlyte
®; Taejun Co., Seoul, Korea) from 6:00 a.m. to 10:00 a.m. 
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taken from suspected lesion using standard biopsy forceps. Bi-
opsy specimens were obtained from the inner margin of ulcer 
in all directions. Each biopsy specimen was immediately im-
mersed (fixed) in 20% formalin solution in separate vials; each 
vial was given a code number to identify the serial order. One 
expert pathologist who was not aware of the code numbers made 
the diagnosis of each biopsy specimen. The diagnoses used for 
single biopsy were one of the following: 1) carcinoma, 2) pre-
sumable carcinoma, 3) benign biopsy, and 4) failed biopsy. In 
the case of 1) or 2), the final diagnosis was considered to be car-
cinoma. 
  Location, size, shape, and macroscopic classifications of the 
lesion suspected of malignancy were recorded immediately af-
ter the procedure by endoscopists. Patient’s age, sex, and prin-
cipal symptoms, and the reason why the patient underwent di-
agnostic endoscopy were recorded after the procedure by nurs-
es in endoscopy room. The data were collected prospectively. 
Reports of pathologic results were reviewed retrospectively, and 
before data analysis, pathologic results were reviewed again ret-
rospectively. 
  The data obtained during this study were expressed as means 
and standard deviations for continuous variables and as frequen-
cies and percentages for categorical variables. For analyzing cu-
mulative diagnostic yields of pathology according to the order 
of endoscopic biopsy specimens, nonparametric Cochrane and 
McNemar tests were used. Statistical significance was accepted 
for P < 0.05. All analyses were conducted using SPSS version 
13.0 (SPSS Inc, Chicago, IL, USA).
Ethical statement 
This study protocol was approved by the institutional review 
board of Kangbuk Samsung Hospital (Approval number: KBC-
11125). Written informed consent was exempted, and all data 
collected from this study were kept confidential.
RESULTS 
A total of 91 patients with 59 advanced gastric and 32 colorectal 
cancers were enrolled. There was no significant difference in age 
and gender (Age: 60.3 ± 13.2 yr in gastric cancer patients vs 62.0 
± 14.1 yr in colon cancer patients). The male to female ratio was 
2.68 in gastric cancer patients and 2.2 in colon cancer patients. 
Frequent sites of advanced gastric cancer were the antrum (47.4 
%) and body (42.4%), and those of colon cancer were the sigmoid 
colon (53.1%) and rectum (25.0%) as shown in Table 1. 
  In macroscopic and pathologic classifications, Borrmann type 
3 (n = 36, 61.0%) and tubular-adenocarcinoma (n = 47, 79.7%) 
were most frequently reported in advanced gastric cancer and 
Borrmann type 3 (n = 15, 46.9%) and tubular-adenocarcinoma 
(n = 28, 87.5%) were most frequently reported in advanced co-
lon cancer (Table 2, 3). 
  Examination of the diagnostic yield of pathology according 
to the number of endoscopic biopsy specimens showed that ini-
tial biopsies had a diagnostic accuracy of 81.3% in advanced gas-
tric cancer and 78.1% in advanced colon cancer. 
  Cumulative rates of diagnostic accuracy from the first to sec-
ond biopsy, the first to third, and the first to fourth were 94.9%, 
98.3%, and 98.3%, respectively, in advanced gastric cancer, 
whereas the rates were 87.5%, 93.8%, and 98.3% in advanced 
colon cancer (Fig. 1). Further additional biopsies did not show 
any additional benefit in diagnostic rates. Only one case of gas-
Table 1. Location of advanced gastric cancer (AGC) and colon cancer (ACC) 
Cancer       Location No. (%)
AGC Antrum
Angle
Body
   Lower
   Middle
   Upper
Cardia
28 (47.4)
3 (5.1)
 
6 (10.2)
14 (23.7)
5 (8.5)
3 (5.1)
ACC Cecum
Ascending colon
Transverse colon
Descending colon
Sigmoid colon
Rectum
1 (3.1)
2 (6.2)
3 (9.4)
1 (3.1)
17 (53.1)
8 (25.0)
Table 2. Macroscopic classification of advanced gastric and colorectal cancer
Cancer
Borrmann type
1 2 3 4
AGC No. (%) 3 (5.1) 16 (27.1) 36 (61.0)    4 (6.8)
ACC No. (%) 3 (9.4) 14 (43.7) 15 (46.9) 0 (0)
AGC, advanced gastric cancer; ACC, advanced colon cancer.
Table 3. Pathology of advanced gastric and colorectal cancer
Cancer
Pathology
Tubular-adenocarcinoma
Mucinous  
adenocarcinoma
Signet ring  
cell cancer
Others Well  
differentiated
Moderately  
differentiated
Poorly  
differentiated
AGC No. (%) 47 (79.7)
  5 (8.5)                       21 (35.6)                     21 (35.6)
2 (3.4)   8 (13.5) 2 (3.4)
ACC No. (%) 28 (87.5)
4 (12.5)                     22 (68.7)                       2 (6.2)
1 (3.1) 1 (3.1) 2 (6.2)
Histology of advanced gastric and colorectal cancer was classified in accordance with WHO classification. AGC, advanced gastric cancer; ACC, advanced colon cancer.Choi Y, et al.  •  Biopsy in Advanced Gastrointestinal Cancer
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tric cancer and two cases of colon cancer were non-diagnostic 
with five biopsy specimens.
DISCUSSION 
Until recently, it was believed that multiple biopsies can increase 
pathologic diagnosis rates of gastric or colon cancer during en-
doscopic examination. However, this study showed that the num-
ber of biopsies needed to diagnose malignant cells during en-
doscopy could be reduced to three or four. 
  Several studies have been published about factors that influ-
ence biopsy results in gastrointestinal malignancy diagnoses. In 
one study, diagnostic accuracy improved with an increase in the 
number of biopsy specimens and reached 100% when 6 or more 
biopsy specimens were obtained (7). In another study, it was rec-
ommended that at least 10 biopsy specimens should be taken 
from suspected malignant gastric lesions, and the overall endo-
scopic biopsy accuracy was 99.8% (8). Others found that when 
eight specimens were taken, greater than 99% chance of correct 
tissue diagnosis in gastrointestinal cancer during endoscopy was 
seen (4). However, all these reports were published 30 yr ago. In 
a report published 20 yr ago, if two biopsy specimens were taken, 
the correct diagnosis was achieved in 95.8% of cases, and that 
rate increased to 97.9% and 100% if 4 or 6 specimens were tak-
en, respectively, in esophageal cancers (6). In the case of gastric 
cancers, 97% accuracy could be achieved when 5 biopsy speci-
mens were taken (3). In a recent study of missed diagnosis in 
patients with upper gastrointestinal cancers, 77% of patients had 
fewer than 4 biopsy samples taken at previous endoscopies, com-
pared with 37% at the final endoscopy (9). However, a thorough 
analysis in that study revealed that in only one case was insuffi-
cient number of biopsy samples taken, from a total of 16 cases. 
Additionally, the number of biopsy specimens and gross endo-
scopic shapes of lesions were not described. Therefore, the rea-
son for the missed diagnoses is not clear in that report.
  Actually, all the number of biopsy specimens is not the most 
important factor in the diagnosis of gastric cancer during endos-
copy; the acquisition of appropriate tissue from the lesion with 
exact targeting is more important. Advance in endoscopic instru-
mentation have led to electronic rather than fiber-optic scopes, 
and the shaft is more flexible. Endoscopic vision has improved, 
the visual field is wider, and the scope can access inner portions 
that were unviewable in the past. Biopsy forceps also evolved 
and became more delicate and able to punch adequate amount 
of tissues. Such progresses make it easier to target suspicious 
lesions for biopsy during endoscopy and reduce the number of 
biopsy specimens for tissue diagnosis. 
  The biopsy site is also important. In a previous study, tissue 
obtained from the rim of an ulcer showed more accurate diag-
nostic results compared to those taken from ulcer base because 
insufficient tissue structure consisting of only necrotic debris and 
exudates may be present in ulcer base (5, 7, 10). Taking biopsy 
specimens from ulcer base has also has a higher risk of bleed-
ing due to exposed submucosal vessels within ulcer base. In our 
study, the diagnostic accuracy from ulcer base was also lower 
than that from the inner margin. Therefore, targeting of an ap-
propriate site is very important and especially targeting of first a 
few biopsies is more important, especially if taking multiple spec-
imens from the same site, as the endoscopic visual field might 
be impaired after the first biopsy. The biopsy itself can trans-
form original shape of the target lesion, and bleeding by the ini-
tial biopsy can cover the lesion and result in poor peripheral vi-
sion. If a former biopsy has performed, it may also be more dif-
ficult to obtain correct specimen.
  Along the increase in the number of endoscopic examina-
tions, experiences of gastroscopy or colonoscopy and knowledge 
about endoscopic lesions have been accumulating. In addition 
to their own personal experiences, endoscopists have learned 
about many other cases from books, journals, graduate or con-
tinuing medical education at conferences, and even via Inter-
net. Therefore, experienced endoscopists can differentiate ma-
lignant lesions from benign lesions by examination of its gross 
appearance and need not take excessive number of biopsies.
  Pathologists also become experts with their growing knowl-
edge and experience in the gastrointestinal department. In large 
centers, gastrointestinal pathology specialists are available to 
give their expert opinions and help with diagnosis in difficult 
cases. There have been many developments in histological diag-
nosis as well. Many kinds of special stains have been introduced 
and are now utilized in clinical practice. Therefore, pathologic 
diagnosis does not depend on only H & E staining, and pathol-
ogists can make diagnoses by other complementary special 
staining with the same biopsy specimens. 
  In our study, there was only one case in which malignant cells 
were not found in any of the gastroscopic biopsies, even a sub-
Fig. 1. Cumulative diagnostic yield according to the order of endoscopic biopsy spec-
imens in advanced gastric cancer and colon cancer.
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sequent seventh biopsy. It was a case of advanced gastric can-
cer of Borrmann type 4. Due to its peculiar biological properties, 
in which a submucosal spread of malignant cells was present 
without a mucosal lesion, malignant cells could not be obtained 
by subsequent repeated endoscopic biopsy. A second endosco-
py for re-biopsy a few days later also failed to give us malignant 
cells. In this case, we could diagnose malignancy with radiologic 
studies, and pathologic diagnosis was confirmed after surgery. 
  Among the colon cancers surveyed in this study, two cases 
were not diagnosed by endoscopic biopsy preoperatively. In 
these cases, because of luminal obstruction by the cancer mass, 
exact targeting with biopsy forceps was not possible. In contrast 
to the stomach, lumen of the colon is not wide, and retroflection 
of the scope is not possible. Thus, targeting accuracy in colon 
cancer is lower than that in the stomach. They underwent sur-
gery with an impression of malignant stenosis to relieve obstruc-
tion and also pathologically diagnosed after surgery.
  In summary, the diagnostic accuracy of endoscopic biopsy 
for advanced gastric or colon malignancy is increased accord-
ing to the number of biopsies performed, up to the third biopsy. 
Further biopsies do not increase rates of correct diagnosis. Addi-
tional biopsies may increase the workload of both endoscopists 
and pathologists. The collection of multiple specimens also pro-
longs endoscopic procedure and provokes more discomfort to 
the patient. Furthermore, an increase in the number of biopsies 
will increase the risk of bleeding from the biopsy site. Therefore, 
we recommend 3 or 4 biopsy specimens from one viable tissue 
for pathologic diagnosis of advanced gastrointestinal malignan-
cy during endoscopy. In cases of negative results with the endo-
scopic impression of malignancy, re-biopsy with careful target-
ing should be performed.
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